GLP-1 advancements, regulatory news, and compound comparisons.https://glpeptidesciences.com/https://glpeptidesciences.com/news/what-happened-to-peptide-sciences/https://glpeptidesciences.com/news/what-happened-to-peptide-sciences/"Peptide Sciences" is one of the most-searched names in the research-peptide world. Here's what people are actually asking, why the search interest persists, and how to evaluate any vendor — without us pretending to be a company we're not.Thu, 28 May 2026 00:00:00 GMThttps://glpeptidesciences.com/news/glp1-2026-pipeline/https://glpeptidesciences.com/news/glp1-2026-pipeline/Dual and triple incretin agonists, oral formulations, and muscle-preservation combinations are reshaping the metabolic landscape. A neutral look at what's approved, what's in trials, and what's still hype.Wed, 20 May 2026 00:00:00 GMT